This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Beyond the Abstracts
Urologic Oncology
Renal Cancer
Beyond the Abstracts
A review of the current role of targeted therapy in the treatment of metastatic renal carcinoma, "Beyond the Abstract," by Paulo Jaworski, MD
June 17, 2014
Washington University long-term experience with renal cryoablation versus robot-assisted partial nephrectomy, "Beyond the Abstract," by Eric H. Kim, MD
June 11, 2014
Renal cancer-selective englerin A induces multiple mechanisms of cell death and autophagy, "Beyond the Abstract," by Ayse Batova, PhD
June 6, 2014
A Malaysian single centre perspective of clinical prognostic factors and survival outcome in renal cell carcinoma patients, "Beyond the Abstract," by Ning Yi Yap
May 16, 2014
Management of renal cell carcinoma with level I tumor thrombi using a combined retroperitoneoscopic and transperitoneal laparoscopic technique, "Beyond the Abstract," by Oner Sanli and Abubekir Boguk
May 14, 2014
A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma, "Beyond the Abstract," by Aiko Kurisaki-Arakawa and Tsuyoshi Saito
May 9, 2014
Kidney injury molecule-1 (KIM-1) may become a kidney “prostate specific antigen (PSA)” for renal cell carcinoma, "Beyond the Abstract," by Ping L. Zhang, MD, PhD, FCAP, FASN and Jason M. Hafron, MD
April 12, 2014
Sunitinib-treated patients with renal cell carcinoma and benign prostatic hyperplasia expereince shrinkage of prostate volume, "Beyond the Abstract," by Takashi Hatano, MD, PhD
March 31, 2014
Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma, "Beyond the Abstract," by Michael Aitchison, MD, FRCS
March 18, 2014
Renal cell carcinoma with venous tumor thrombus extension: A retrospective study of factors affecting survival, "Beyond the Abstract," by Kazuto Ito, MD, PhD and Mikio Kobayashi, MD, PhD
March 18, 2014
Metastatic renal cell carcinoma: How to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor, "Beyond the Abstract," by Roberto Sabbatini, MD, et al
March 5, 2014
Differentiation, with multiphase CT, of clear cell renal cell carcinoma and papillary renal cell carcinoma, two distinct histological types, "Beyond the Abstract," by David Laszlo Tarnoki, MD, et al
February 13, 2014
Development of a clinical prediction model for assessment of malignancy risk in Bosniak III renal lesions, "Beyond the Abstract," by Ajit H. Goenka, MD and Erick M. Remer, MD
February 12, 2014
Urine screening by surface-enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry followed by biomarker identification, "Beyond the Abstract," by Gilda Alves, PhD and Antonio Augusto Ornellas, MD, PhD
January 14, 2014
Management of locally advanced renal cell carcinoma with invasion of the duodenum, "Beyond the Abstract," by Andrew T. Schlussel, DO and Linda L. Wong, MD
January 11, 2014
A review of current management considerations for the incidentally detected small renal mass, "Beyond the Abstract," by Philippe E. Spiess, MD, MS, FRCS(C), FACS
November 12, 2013
Association with disease-free and cancer-specific survival in lymphovascular invasion in clear cell renal cell carcinoma, "Beyond the Abstract," by Michael Belsante, MD
November 7, 2013
Cumulative number of altered biomarkers in mTOR gene pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma, "Beyond the Abstract," by Oussama Darwish, MD and Vitaly Margulis, MD
November 2, 2013
Pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma: A case report, "Beyond the Abstract," by Yoshinobu Saito, MD, PhD
October 16, 2013
Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy, "Beyond the Abstract," by Robert Uzzo, MD, FACS, et al
October 4, 2013
Page 13 of 17
Start
Prev
8
9
10
11
12
13
14
15
16
17
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free